Search

everythinglearnresearchcommunity

for

Search:↓

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

AGA might indicate higher risk for severe COVID-19.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Psoriasis treatments don't raise severe COVID-19 risk, except for acitretin.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Some people still have COVID-19 symptoms after 90 days, especially older patients and those with severe initial symptoms, but most return to normal.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Women with PCOS may have a higher risk of severe COVID-19 due to hormonal imbalances and vitamin D deficiency.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Testosterone's effects on COVID-19 are unclear and need more research.